AAAAAA

   
Results: 1-13 |
Results: 13
ASSESSMENT OF FUNCTION AND SURVIVAL AS MEASURES OF RENAL GRAFT OUTCOME FOLLOWING KIDNEY AND KIDNEY-PANCREAS TRANSPLANTATION IN TYPE-I DIABETICS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM UBER L RAJAGOPALAN PR
Citation: V. Douzdjian et al., ASSESSMENT OF FUNCTION AND SURVIVAL AS MEASURES OF RENAL GRAFT OUTCOME FOLLOWING KIDNEY AND KIDNEY-PANCREAS TRANSPLANTATION IN TYPE-I DIABETICS, Clinical transplantation, 12(2), 1998, pp. 93-98
ASSESSMENT OF FUNCTION AND SURVIVAL AS MEASURES OF RENAL GRAFT OUTCOME AFTER KIDNEY AND KIDNEY-PANCREAS TRANSPLANTS IN TYPE-I DIABETICS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM RAJAGOPALAN PR
Citation: V. Douzdjian et al., ASSESSMENT OF FUNCTION AND SURVIVAL AS MEASURES OF RENAL GRAFT OUTCOME AFTER KIDNEY AND KIDNEY-PANCREAS TRANSPLANTS IN TYPE-I DIABETICS, Transplantation proceedings, 30(2), 1998, pp. 273-273
LACK OF DIFFERENCE OF GRAFT-SURVIVAL OR FUNCTION IN AFRICAN-AMERICAN LIVING-RELATED TRANSPLANTS
Authors: BUNKE CM DOUZDJIAN V RAJAGOPALAN PR BALIGA PK SINDHI R
Citation: Cm. Bunke et al., LACK OF DIFFERENCE OF GRAFT-SURVIVAL OR FUNCTION IN AFRICAN-AMERICAN LIVING-RELATED TRANSPLANTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3149-3149
RISK-FACTORS FOR CLINICAL FAILURE FOLLOWING STATISTICALLY SUCCESSFUL KIDNEY-TRANSPLANTS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM UBER L RAJAGOPALAN PR
Citation: V. Douzdjian et al., RISK-FACTORS FOR CLINICAL FAILURE FOLLOWING STATISTICALLY SUCCESSFUL KIDNEY-TRANSPLANTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3167-3167
A UTILITY-BASED DECISION-ANALYSIS MODEL FOR TREATMENT OF TYPE-I DIABETICS WITH ESRD - DIALYSIS VS KIDNEY-TRANSPLANT VS KIDNEY-PANCREAS TRANSPLANT
Authors: DOUZDJIAN V BUNKE CM FERRARA D SILVESTRI G
Citation: V. Douzdjian et al., A UTILITY-BASED DECISION-ANALYSIS MODEL FOR TREATMENT OF TYPE-I DIABETICS WITH ESRD - DIALYSIS VS KIDNEY-TRANSPLANT VS KIDNEY-PANCREAS TRANSPLANT, Journal of the American Society of Nephrology, 8, 1997, pp. 3168-3168
WHO SHOULD BE TRANSPLANTED WITH KIDNEYS FROM LESS-THAN OPTIMAL DONORS
Authors: DOUZDJIAN V BUNKE CM BAILLIE GM UBER L RAJAGOPALAN PR
Citation: V. Douzdjian et al., WHO SHOULD BE TRANSPLANTED WITH KIDNEYS FROM LESS-THAN OPTIMAL DONORS, Journal of the American Society of Nephrology, 8, 1997, pp. 3169-3169
COMPARISON OF 2 ANTIMICROBIAL PROPHYLAXIS REGIMENS AFTER KIDNEY-PANCREAS TRANSPLANTS
Authors: BAILLIE GM DOUZDJIAN V SCHOLZ K UBER L BUNKE CM RAJAGOPALAN PR
Citation: Gm. Baillie et al., COMPARISON OF 2 ANTIMICROBIAL PROPHYLAXIS REGIMENS AFTER KIDNEY-PANCREAS TRANSPLANTS, Journal of the American Society of Nephrology, 8, 1997, pp. 3298-3298
OUTCOMES OF SINGLE ORGANISM PERITONITIS IN PERITONEAL-DIALYSIS - GRAM-NEGATIVES VERSUS GRAM-POSITIVES IN THE NETWORK-9 PERITONITIS STUDY
Authors: BUNKE CM BRIER ME GOLPER TA
Citation: Cm. Bunke et al., OUTCOMES OF SINGLE ORGANISM PERITONITIS IN PERITONEAL-DIALYSIS - GRAM-NEGATIVES VERSUS GRAM-POSITIVES IN THE NETWORK-9 PERITONITIS STUDY, Kidney international, 52(2), 1997, pp. 524-529
SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2183-2186
THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 968-970
ABBREVIATED PHARMACOKINETIC (PK) PROFILES IN AREA-UNDER-THE-CURVE (AUC) MONITORING OF CYCLOSPORINE (CSA) THERAPY IN DE-NOVO RENAL-TRANSPLANT PATIENTS
Authors: MARSH C PRUETT T MIN D THOMPSON J WAID CT BUNKE CM KLEIN JB PESCOVITZ MD POLLAK R VASQUEZ E BARONE G WOMBOLT D STINSON J WONG R CHOC MG HWANG DS CHANG CT
Citation: C. Marsh et al., ABBREVIATED PHARMACOKINETIC (PK) PROFILES IN AREA-UNDER-THE-CURVE (AUC) MONITORING OF CYCLOSPORINE (CSA) THERAPY IN DE-NOVO RENAL-TRANSPLANT PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1103-1103
CORRELATION OF PHENYTOIN PROTEIN-BINDING WITH CLINICAL-PARAMETERS AFTER RENAL-TRANSPLANTATION
Authors: MARX MA MONAGHAN MS OLSEN KM BUNKE CM EVANOFF GV
Citation: Ma. Marx et al., CORRELATION OF PHENYTOIN PROTEIN-BINDING WITH CLINICAL-PARAMETERS AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1022-1022
CASE-HISTORY ROUND-TABLE DISCUSSION
Authors: BURROWS L FINN W HARMON W BUNKE CM JORDAN M RAJAGOPALAN PR WILLIAMS P WAID T KELLY A
Citation: L. Burrows et al., CASE-HISTORY ROUND-TABLE DISCUSSION, Transplantation proceedings, 26(5), 1994, pp. 37-45
Risultati: 1-13 |